{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "caaecd46-bd6f-4e1a-9010-2bac0c0ad662",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Only if using Jupyter + PySpark\n",
    "import os\n",
    "os.environ[\"PYSPARK_SUBMIT_ARGS\"] = \"--packages org.apache.hadoop:hadoop-aws:3.3.6,com.amazonaws:aws-java-sdk-bundle:1.12.374 pyspark-shell\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "fb947911-a238-4724-8d44-9dfb7f4f1611",
   "metadata": {},
   "outputs": [],
   "source": [
    "import findspark\n",
    "findspark.init(\"/opt/spark\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "dabcfcb6-1a0c-4064-9a1b-0227d5e2238a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/opt/spark/python/pyspark/core/context.py:358: RuntimeWarning: Failed to add file [/home/spark/.local/lib/python3.10/site-packages/vaderSentiment] specified in 'spark.submit.pyFiles' to Python path:\n",
      "  /opt/spark/python\n",
      "  /tmp/spark-ee5edadb-6979-49a8-922e-ce3393a41c21/userFiles-7b551373-f8cb-4b9c-96a3-5a22b29d56d1\n",
      "  /tmp/spark-ee5edadb-6979-49a8-922e-ce3393a41c21/userFiles-1ea7bc59-467f-4e94-8256-fe4ab620bc78\n",
      "  /opt/spark/python/lib/py4j-0.10.9.9-src.zip\n",
      "  /opt/spark/python\n",
      "  /opt/spark/python/lib/py4j-0.10.9.9-src.zip\n",
      "  /usr/lib/python310.zip\n",
      "  /usr/lib/python3.10\n",
      "  /usr/lib/python3.10/lib-dynload\n",
      "  \n",
      "  /usr/local/lib/python3.10/dist-packages\n",
      "  /usr/lib/python3/dist-packages\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "from pyspark.sql import SparkSession\n",
    "\n",
    "# Stop any old session first\n",
    "try:\n",
    "    spark.stop()\n",
    "except:\n",
    "    pass\n",
    "\n",
    "spark = (\n",
    "    SparkSession.builder\n",
    "    .appName(\"MinioTest\")\n",
    "    .config(\"spark.master\", \"spark://spark-master:7077\")\n",
    "\n",
    "    # S3A core config\n",
    "    .config(\"spark.hadoop.fs.s3a.impl\", \"org.apache.hadoop.fs.s3a.S3AFileSystem\")\n",
    "    .config(\"spark.hadoop.fs.s3a.endpoint\", \"http://minio:9000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.access.key\", \"minio\")\n",
    "    .config(\"spark.hadoop.fs.s3a.secret.key\", \"minio123\")\n",
    "    .config(\"spark.hadoop.fs.s3a.path.style.access\", \"true\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.ssl.enabled\", \"false\")  # <-- important for HTTP MinIO\n",
    "\n",
    "    # Credentials providers (no AWS v2 class)\n",
    "    .config(\n",
    "        \"spark.hadoop.fs.s3a.aws.credentials.provider\",\n",
    "        \"org.apache.hadoop.fs.s3a.SimpleAWSCredentialsProvider,\"\n",
    "        \"org.apache.hadoop.fs.s3a.TemporaryAWSCredentialsProvider\"\n",
    "    )\n",
    "\n",
    "    # Multipart cleanup: override \"24h\" etc with numeric ms\n",
    "    .config(\"spark.hadoop.fs.s3a.multipart.purge.age\", \"86400000\")      # 24h\n",
    "    .config(\"spark.hadoop.fs.s3a.multipart.purge.interval\", \"3600000\")  # 1h\n",
    "\n",
    "    # --- S3A timeouts (ms) ---\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.timeout\", \"60000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.request.timeout\", \"60000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.establish.timeout\", \"60000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.acquisition.timeout\", \"60000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.idle.time\", \"60000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.ttl\", \"300000\")\n",
    "\n",
    "    # --- S3A thread pool / connection pool (ALL numeric) ---\n",
    "    .config(\"spark.hadoop.fs.s3a.threads.max\", \"96\")\n",
    "    .config(\"spark.hadoop.fs.s3a.threads.keepalivetime\", \"60000\")  # <--- key that defaulted to \"60s\"\n",
    "    .config(\"spark.hadoop.fs.s3a.connection.maximum\", \"200\")\n",
    "    .config(\"spark.hadoop.fs.s3a.max.total.tasks\", \"1000\")\n",
    "    .config(\"spark.hadoop.fs.s3a.max.metadata.tasks\", \"100\")\n",
    "    .config(\"spark.hadoop.fs.s3a.max.total.connections\", \"200\")\n",
    "\n",
    "    # --- Spark-level timeouts as numbers ---\n",
    "    .config(\"spark.files.fetchTimeout\", \"60000\")\n",
    "    .config(\"spark.network.timeout\", \"600000\")\n",
    "    .config(\"spark.rpc.askTimeout\", \"600000\")\n",
    "    \n",
    "    # (plus the timeouts / thread configs you already set)\n",
    "\n",
    "    .config(\"spark.submit.pyFiles\", \"/home/spark/.local/lib/python3.10/site-packages/vaderSentiment\")\n",
    "    .getOrCreate()\n",
    ")\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "81b65108-dcfb-42aa-8488-17ff501836dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.append(\"/home/spark/.local/lib/python3.10/site-packages\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "57a7bb5b-28ff-40ed-8183-5aed31b78d05",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Requirement already satisfied: vaderSentiment in /home/spark/.local/lib/python3.10/site-packages (3.3.2)\n",
      "Requirement already satisfied: requests in /usr/local/lib/python3.10/dist-packages (from vaderSentiment) (2.32.5)\n",
      "Requirement already satisfied: charset_normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (3.4.4)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (3.11)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (2.6.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (2025.11.12)\n"
     ]
    }
   ],
   "source": [
    "!pip install vaderSentiment"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "79fcde86-e6c6-4eba-890d-a9eac7170874",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyspark.sql.functions import length,  regexp_replace, trim, col, to_timestamp, to_date, udf,size, split, pandas_udf, PandasUDFType\n",
    "from pyspark.sql.types import BooleanType, DoubleType\n",
    "from pyspark.sql import functions as F\n",
    "from pyspark.sql.window import Window\n",
    "from urllib.parse import urlparse\n",
    "from vaderSentiment.vaderSentiment import SentimentIntensityAnalyzer\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "8801deed-a48f-4082-8911-427a1338fcb8",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |pub_date  |url                                                                                                                                                                                                                           |\n",
      "+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|Media Release\\nCOPENHAGEN, Denmark; November 10, 2025\\nGenmab A/S (Nasdaq: GMAB) (Genmab) announced today that it and its wholly owned subsidiary Genmab Finance LLC (Genmab Finance) intend to offer, subject to market and other conditions, $1.5 billion of senior secured notes due 2032 (the Secured Notes) and $1.0 billion of senior unsecured notes due 2033 (the Unsecured Notes, and together with the Secured Notes, the Notes).\\nGenmab also launched the syndication of a new $2.0 billion senior secured term loan B facility, which term loan B facility is in addition to a $1.0 billion senior secured term loan A facility and $500 million senior secured revolving credit facility (collectively, the New Credit Facilities) that Genmab previously syndicated to certain lenders as part of the financing for the pending acquisition (the Acquisition) of Merus N.V. (Merus).\\nGenmab intends to use the net proceeds from this offering of the Notes, together with borrowings under the New Credit Facilities and cash on hand, to fund the consideration payable in connection with the Acquisition of Merus and related fees and expenses in connection with the Acquisition, the borrowings under the New Credit Facilities and the issuance of the Notes.\\nPrior to the Acquisition closing, the Notes and the related guarantees from Genmab subsidiaries will be secured solely by segregated securities accounts of Genmab in which the gross proceeds of the Notes will be held. Following the purchase of all Merus common shares tendered in the previously announced tender offer by Genmab, the Secured Notes will be secured by a first priority security interest in certain assets of Genmab and its subsidiaries that will guarantee the obligations under the New Credit Facilities, in accordance with certain customary practices in the relevant jurisdictions, and subject to certain thresholds, exceptions and permitted liens. The Secured Notes will be unconditionally guaranteed on a senior secured basis and the Unsecured Notes will be unconditionally guaranteed on a senior unsecured basis by certain subsidiaries of Genmab that will guarantee the obligations under the New Credit Facilities.\\nThe indentures governing the Notes are expected to contain customary covenants that, among other things, restrict, with certain exceptions, the ability of each of Genmab and its subsidiaries to incur additional debt, pay dividends, make certain other restricted payments, incur debt secured by liens, dispose of assets, engage in consolidations and mergers or sell or transfer all or substantially all of its assets.\\nThe Notes will not be registered under the Securities Act of 1933, as amended (the Securities Act), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from the registration requirements of or in a transaction not subject to the Securities Act and any state or other applicable securities laws. Accordingly, the offering of the Notes is available only to persons who are either (1) reasonably believed to be qualified institutional buyers as defined in Rule 144A under the Securities Act or (2) non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes will be subject to restrictions on transferability and resale and may not be transferred or resold except in compliance with the registration requirements of the Securities Act or pursuant to an exemption therefrom and in compliance with any state or other applicable securities laws.\\nThis announcement shall not constitute an offer to sell or a solicitation of an offer to purchase any securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The offering of the Notes may be made only by means of an offering memorandum.\\nContact:\\nMarisol Peron, Senior Vice President, Global Communications & Corporate Affairs\\nT: +1 609 524 0065; E:mmp@genmab.com\\nAndrew Carlsen, Vice President, Head of Investor Relations\\nT: +45 3377 9558; E:acn@genmab.com\\nForward-looking Statements\\nIn this announcement, we make statements concerning our expectations, beliefs, plans, objectives, goals, strategies, and future events or performance, including, but not limited to, the statements about the proposed offering of Notes, our intention to issue the Notes and the expected use of proceeds. Genmab cautions investors that any forward-looking statements or projections made by Genmab, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in Genmabs filings with the SEC, including those included in Genmabs most recent Annual Report on Form 20-F, which is available at www.genmab.com and www.sec.gov. Genmab is providing the information in this announcement as of this date, and Genmab does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.\\nGenmab A/S and/or its subsidiaries own the following trademarks: Genmab; the Y-shaped Genmab logo; Genmab in combination with the Y-shaped Genmab logo; HuMax; DuoBody; HexaBody; DuoHexaBody, HexElect and KYSO.\\nMedia Release no. 22\\nCVR no. 2102 3884\\nLEI Code 529900MTJPDPE4MHJ122\\nGenmab A/S\\nCarl Jacobsens Vej 30\\n2500 Valby\\nDenmark\\nAttachment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |2025-11-10|https://www.globenewswire.com/news-release/2025/11/10/3184410/0/en/Genmab-Announces-Proposed-Private-Offering-of-Senior-Secured-Notes-and-Senior-Unsecured-Notes-and-Syndication-of-New-Senior-Secured-Term-Loan-Facility.html|\n",
      "|Company Announcement\\n- Net sales of DARZALEX in the third quarter of 2025 totaled USD 3,672 million\\n- Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)\\nCOPENHAGEN, Denmark; October 14, 2025  Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO in the U.S.), as reported by J&J were USD 3,672 million in the third quarter of 2025. Net trade sales were USD 2,088 million in the U.S. and USD 1,584 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC products, under the exclusive worldwide license to J&J to develop, manufacture and commercialize daratumumab.\\nAbout Genmab\\nGenmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For more than 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmabs vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines.\\nEstablished in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.\\nContact:\\nMarisol Peron, Senior Vice President, Global Communications & Corporate Affairs\\nT: +1 609 524 0065; E: mmp@genmab.com\\nAndrew Carlsen, Vice President, Head of Investor Relations\\nT: +45 3377 9558; E: acn@genmab.com\\nThis Company Announcement contains forward looking statements. The words believe, expect, anticipate, intend and plan and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmabs most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmabs most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.\\nGenmab A/S and/or its subsidiaries own the following trademarks: Genmab; the Y-shaped Genmab logo; Genmab in combination with the Y-shaped Genmab logo; HuMax; DuoBody; HexaBody; DuoHexaBody, HexElect and KYSO. DARZALEX and DARZALEX FASPRO are trademarks of Johnson & Johnson.\\nCompany Announcement no. 47\\nCVR no. 2102 3884\\nLEI Code 529900MTJPDPE4MHJ122\\nGenmab A/S\\nCarl Jacobsens Vej 30\\n2500 Valby\\nDenmark\\nAttachment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |2025-10-14|https://www.globenewswire.com/news-release/2025/10/14/3165984/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Third-Quarter-of-2025.html                                                                          |\n",
      "|DUBLIN, IRELAND  October 22, 2025  Avadel Pharmaceuticals (NASDAQ: AVDL) shareholders are celebrating today as Alkermes plc (NASDAQ: ALKS) announced a definitive agreement to acquire the company for a staggering $2.1 billion. The news sent Avadel's stock price soaring in premarket trading, reflecting a significant premium offered to its investors. This strategic move by Alkermes is poised to reshape the sleep medicine market, providing a substantial boost to its commercial portfolio and pipeline.\\nThe acquisition, valued at up to $2.1 billion, will see Avadel shareholders receive $18.50 per share in cash at closing, along with a contingent value right (CVR) of $1.50 per share, tied to the future FDA approval of LUMRYZ for idiopathic hypersomnia. This immediate market reaction underscores the financial appeal of the deal, which offers Avadel shareholders a premium of approximately 38% over the company's weighted average trading price in the three months preceding the announcement, and a 12% premium to its closing price on October 21, 2025.\\nA Strategic Leap into Sleep Medicine: Details of the Landmark Acquisition\\nThe acquisition of Avadel Pharmaceuticals by Alkermes represents a pivotal moment for both companies, marking a significant expansion for Alkermes into the lucrative sleep medicine market. The core of this deal is Avadel's FDA-approved LUMRYZ (sodium oxybate), a once-nightly treatment for narcolepsy that has demonstrated impressive commercial traction since its launch in 2023. As of June 30, 2025, LUMRYZ was already serving approximately 3,100 patients and is projected to generate between $265 million and $275 million in net revenues for 2025.\\nThe transaction, announced today, October 22, 2025, is structured to provide immediate and potential future value to Avadel shareholders. The upfront cash payment of $18.50 per share at closing is complemented by a non-transferable CVR, which could deliver an additional $1.50 per share if LUMRYZ secures final FDA approval for idiopathic hypersomnia in adults by the end of 2028. This CVR mechanism highlights Alkermes' confidence in Avadel's pipeline and its commitment to maximizing the value of its acquired assets. The boards of directors of both companies have unanimously approved the acquisition, which is anticipated to close in the first quarter of 2026, pending regulatory clearances, Avadel shareholder approval, and Irish High Court sanction.\\nFor Alkermes, the strategic rationale behind this acquisition is clear: to accelerate its growth and diversify its revenue streams. Beyond LUMRYZ, the deal also provides Alkermes with a strong foundation to advance its own narcolepsy drug candidate, alixorexton, into a Phase 3 program. The company expects to finance the acquisition through a combination of cash on hand and new debt issuance, with the transaction projected to be immediately accretive to Alkermes' earnings upon its completion. This move is a bold statement from Alkermes, signaling its intent to become a dominant player in the central nervous system (CNS) therapeutic area, particularly within sleep disorders.\\nMarket Repercussions: Who Wins and Who Loses in the New Landscape\\nThe acquisition of Avadel Pharmaceuticals (NASDAQ: AVDL) by Alkermes plc (NASDAQ: ALKS) creates clear winners and sets the stage for a competitive re-evaluation within the pharmaceutical industry, particularly in the sleep disorder segment. The most immediate beneficiaries are Avadel's shareholders, who stand to gain substantially from the significant premium offered in the deal. The upfront cash payment of $18.50 per share, coupled with the potential for an additional $1.50 per share through the CVR, represents a robust return on investment, reflecting the successful development and commercialization of LUMRYZ. This outcome validates Avadel's strategic focus and execution in bringing an innovative narcolepsy treatment to market.\\nAlkermes plc (NASDAQ: ALKS) emerges as a major winner, significantly bolstering its product portfolio and market presence. With LUMRYZ already generating substantial revenue and demonstrating strong patient uptake, Alkermes gains immediate access to a proven, high-growth asset. This acquisition not only diversifies Alkermes' revenue streams but also strategically positions it as a key player in the sleep medicine market, an area with considerable unmet medical needs. Furthermore, the deal provides a synergistic opportunity for Alkermes to advance its own narcolepsy candidate, alixorexton, leveraging Avadel's established expertise and commercial infrastructure in the sleep disorder space. The anticipated immediate accretion to Alkermes' earnings upon closing further underscores the financial benefits of this strategic maneuver.\\nWhile the immediate impact on competitors in the narcolepsy and sleep disorder markets may not be a direct \"loss,\" it certainly intensifies the competitive landscape. Companies such as Jazz Pharmaceuticals (NASDAQ: JAZZ), a long-standing leader in the narcolepsy treatment space with its Xyrem and Xywav products, will now face a more formidable and well-resourced competitor in Alkermes. The increased competition could put pressure on pricing, market share, and the need for continued innovation to maintain competitive advantage. Other pharmaceutical companies with pipeline assets targeting sleep disorders will also need to re-evaluate their strategies in light of Alkermes' expanded capabilities and market footprint. The consolidation signifies a maturing market where scale and a diverse product offering are becoming increasingly crucial for sustained success.\\nBroader Implications: Reshaping the Pharmaceutical Landscape\\nThe acquisition of Avadel Pharmaceuticals by Alkermes is more than just a corporate transaction; it's a bellwether for broader trends within the pharmaceutical industry. This deal underscores a persistent drive towards consolidation, particularly in specialized therapeutic areas like central nervous system disorders and sleep medicine. Larger pharmaceutical companies are increasingly looking to acquire innovative, revenue-generating assets to fuel growth, offset patent expirations, and expand into niche markets with high unmet needs. The success of LUMRYZ as a once-nightly narcolepsy treatment exemplifies the industry's focus on developing differentiated therapies that offer significant patient benefits and command strong market positions.\\nThe ripple effects of this acquisition are likely to extend across the competitive landscape. For existing players in the narcolepsy market, such as Jazz Pharmaceuticals (NASDAQ: JAZZ), the entry of a more robust Alkermes (NASDAQ: ALKS) with a leading product like LUMRYZ will necessitate strategic adaptations. Competitors may need to accelerate their own research and development efforts, explore new partnerships, or intensify their marketing and sales strategies to defend or expand their market share. The deal also highlights the increasing valuation placed on commercial-stage assets with strong intellectual property and established patient bases, potentially encouraging smaller biotech firms to focus on late-stage development with an eye towards acquisition.\\nFrom a regulatory perspective, the contingent value right tied to the FDA approval of LUMRYZ for idiopathic hypersomnia demonstrates the ongoing importance of regulatory milestones in deal structures. It provides a mechanism to share risk and reward based on future clinical and regulatory success. Historically, similar acquisitions in the pharmaceutical sector have often led to enhanced investment in the acquired product's lifecycle management and expanded indications, potentially benefiting more patient populations. This transaction also aligns with a broader trend of companies seeking to build comprehensive franchises around specific disease areas, offering a spectrum of solutions to healthcare providers and patients.\\nThe Road Ahead: What Comes Next for Alkermes and the Sleep Market\\nThe immediate future following the Alkermes' acquisition of Avadel Pharmaceuticals is focused on integration and execution. With the transaction slated to close in the first quarter of 2026, the coming months will involve the complex process of merging Avadel's operations, commercial teams, and research initiatives into Alkermes' existing structure. A critical short-term objective for Alkermes (NASDAQ: ALKS) will be to ensure a seamless transition for LUMRYZ (sodium oxybate), maintaining its strong commercial momentum and maximizing patient access. This will involve integrating Avadel's sales and marketing strategies with Alkermes' broader commercial infrastructure to fully capitalize on LUMRYZ's market potential in narcolepsy.\\nLooking further ahead, the acquisition opens up significant long-term possibilities for Alkermes. The successful integration of LUMRYZ is expected to provide a robust revenue stream, allowing Alkermes to strategically invest in further expanding its sleep medicine franchise. A key long-term goal will be to pursue the FDA approval of LUMRYZ for idiopathic hypersomnia, which, if achieved by the end of 2028, would trigger the CVR payment and unlock an even larger market opportunity. Furthermore, the deal provides a strong platform for Alkermes to advance its own narcolepsy drug candidate, alixorexton, into a Phase 3 program, potentially creating a synergistic portfolio of sleep disorder treatments. This strategic pivot positions Alkermes for sustained growth and leadership in a critical therapeutic area.\\nMarket opportunities are likely to emerge as Alkermes leverages its expanded capabilities. The company could explore new indications for LUMRYZ or develop next-generation therapies for sleep disorders. Challenges, however, will include navigating the competitive landscape, particularly with established players like Jazz Pharmaceuticals (NASDAQ: JAZZ), and managing the complexities of drug development and regulatory approvals. Potential scenarios range from Alkermes establishing itself as the undisputed leader in narcolepsy treatment to fostering a highly competitive and innovative market where patient outcomes are continually improved through diverse therapeutic options. The success of this acquisition will largely depend on Alkermes' ability to effectively integrate Avadel's assets and execute on its expanded strategic vision.\\nA New Era for Sleep Medicine: Key Takeaways and Future Outlook\\nThe acquisition of Avadel Pharmaceuticals (NASDAQ: AVDL) by Alkermes plc (NASDAQ: ALKS) for up to $2.1 billion marks a significant turning point in the sleep medicine market and a testament to the value of innovative, commercially successful therapies. The key takeaway from this event is Alkermes' strategic commitment to expanding its footprint in central nervous system disorders, particularly through the immediate integration of Avadel's highly successful narcolepsy treatment, LUMRYZ. For Avadel shareholders, the deal represents a substantial financial victory, securing a considerable premium and a potential upside through the CVR tied to future regulatory success.\\nMoving forward, the market will closely watch Alkermes' ability to seamlessly integrate Avadel's operations and capitalize on the full commercial potential of LUMRYZ. This acquisition is expected to immediately bolster Alkermes' financial performance and provide a strong foundation for future growth in the sleep disorder segment. The increased competition introduced by a more robust Alkermes will likely spur further innovation and strategic realignments among other players in the narcolepsy and sleep medicine landscape, ultimately benefiting patients through broader access to advanced treatments.\\nThe lasting impact of this acquisition will be seen in how it shapes the competitive dynamics and therapeutic advancements in sleep disorders. It underscores the trend of pharmaceutical companies seeking to acquire specialized assets that offer clear differentiation and strong market acceptance. Investors should closely monitor Alkermes' integration progress, the commercial performance of LUMRYZ under its new ownership, and the advancement of its pipeline, particularly the pursuit of additional indications for LUMRYZ and the development of alixorexton. This deal firmly establishes Alkermes as a formidable force in sleep medicine, ushering in a new era of competition and innovation in this critical therapeutic area.\\nThis content is intended for informational purposes only and is not financial advice                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |2025-10-22|https://markets.financialcontent.com/stocks/article/marketminute-2025-10-22-avadel-pharmaceuticals-soars-as-alkermes-announces-21-billion-acquisition                                                                         |\n",
      "|U.S. Blockchain Technology in Healthcare Market: California Shapes the Future of Digital Transformation Through 2026-2035\\nMarket Growth DriversThe U.S. blockchain technology in healthcare market is poised to experience substantial expansion during the forecast period from 2026 to 2035, driven by increasing demand for secure, transparent, and interoperable healthcare data systems. A major growth driver is the rising focus on data integrity and cybersecurity within healthcare ecosystems. As hospitals, insurers, and research institutions generate and exchange vast volumes of patient data, blockchain offers a decentralized and tamper-resistant architecture that ensures data authenticity and access control. This shift is prompting stakeholders to integrate blockchain-based electronic health record (EHR) systems, smart contracts, and patient consent management tools. Over the next decade, growing regulatory alignment, interoperability standards, and cross-sector collaborations are expected to strengthen the U.S. market's innovation outlook, enhancing efficiency, transparency, and trust across healthcare value chains.\\nRequest Free Sample Report @ https://www.researchnester.com/sample-request-5291\\nState-Level Analysis\\nCalifornia represents the largest hub in the U.S. blockchain technology in healthcare market, supported by its mature digital health ecosystem and robust innovation infrastructure. The state's concentration of technology leaders, academic research institutions, and health startups creates a fertile ground for blockchain deployment in medical data exchange, clinical trials, and patient management. Major players in Silicon Valley are collaborating with healthcare providers to develop blockchain-enabled platforms for real-time data access, drug traceability, and clinical interoperability. In addition, California's progressive regulatory stance and commitment to healthcare innovation attract venture capital investments that continually push blockchain-based applications toward commercialization and scalability.\\nTexas is emerging as the fastest-growing state in the U.S. blockchain healthcare landscape, driven by expanding digital health initiatives and strong state-level support for innovation in medical infrastructure. Over the forecast period, Texas is expected to lead adoption in decentralized patient record systems and blockchain-integrated telemedicine. The state's healthcare networks and university research centers are actively exploring blockchain pilots to streamline medical billing, insurance verification, and clinical data validation. Houston's healthcare corridor and Austin's tech ecosystem are accelerating blockchain-driven collaborations between providers and startups. The strategic convergence of technology, policy support, and a growing digital health workforce positions Texas as a national leader in next-generation blockchain-enabled healthcare transformation.\\nAccess our detailed report at: https://www.researchnester.com/reports/blockchain-technology-in-healthcare-market/5291\\nMarket Segmentation\\nThe public segment is anticipated to account for a 60% share of the U.S. blockchain technology in healthcare market by 2035, driven by its scalability, transparency, and cost-efficiency. Public blockchains enable open, verifiable data exchange among healthcare providers, patients, and regulators, ensuring data authenticity without centralized control. This structure appeals particularly to health systems aiming for interoperable records and traceable data transactions. Growing reliance on patient-centric health data management and regulatory pressures for auditability have reinforced the dominance of the public segment. Companies such as IBM, Oracle, and Change Healthcare are deploying public blockchain networks that facilitate secure patient data sharing and identity verification, strengthening trust and collaboration across the healthcare continuum.\\nThe supply chain management segment is expected to hold approximately 42% revenue share over the forecast period, driven by the need for transparency and traceability in pharmaceutical logistics. Blockchain enables end-to-end visibility in the movement of medical supplies, vaccines, and drugs, reducing the risks of counterfeiting, inefficiencies, and regulatory non-compliance. The integration of blockchain in healthcare supply chains is transforming inventory monitoring, supplier validation, and temperature tracking for biologics and vaccines. Companies such as MediLedger, Chronicled, and IBM's Blockchain Transparent Supply initiative are leading innovations in this space, helping manufacturers and distributors establish tamper-proof documentation. As healthcare organizations adopt real-time verification and compliance systems, supply chain blockchain solutions will continue to dominate enterprise deployment strategies in the coming decade.\\nRequest Free Sample Report @ https://www.researchnester.com/sample-request-5291\\nMarket Opportunities\\n1. Interoperable Health Data Ecosystems: One of the most promising opportunities in the U.S. blockchain healthcare market lies in the creation of interoperable health data ecosystems. Blockchain's distributed ledger capabilities enable seamless integration between disparate health systems, allowing for secure exchange of medical histories, prescriptions, and diagnostic results. With interoperability remaining a key challenge under current EHR frameworks, blockchain offers an effective pathway to unify patient data across hospitals, payers, and research entities. Companies investing in open-source blockchain frameworks are enabling healthcare organizations to enhance patient care coordination and analytics. To capitalize on this opportunity, stakeholders should prioritize standardized APIs and smart contract architectures that facilitate seamless cross-platform data exchange while maintaining HIPAA compliance.\\n2. Decentralized Clinical Research and Trials: Another major growth avenue is the use of blockchain in decentralized clinical trials and research data management. Blockchain allows transparent documentation of patient consent, trial protocols, and data integrity, reducing fraud and improving research reproducibility. Pharmaceutical companies and research institutions are leveraging blockchain to automate data validation, accelerate participant recruitment, and ensure ethical oversight. Startups like Triall and ClinTex are pioneering blockchain solutions that digitize the end-to-end clinical research process. As the demand for real-world evidence grows, blockchain-based research networks will enable secure data collaboration and faster drug development cycles. Businesses can seize this opportunity by forming partnerships with technology providers to deploy permissioned blockchain models that ensure both transparency and data privacy.\\nCompetitive Landscape\\nThe competitive landscape of the U.S. blockchain technology in healthcare market is defined by a mix of established technology firms, emerging startups, and collaborative consortiums shaping innovation and adoption trends. Leading players such as IBM, Oracle, and Guardtime are advancing blockchain-based platforms that support secure patient data sharing, insurance claims processing, and regulatory compliance. Startups like BurstIQ, Medicalchain, and Healthereum are differentiating through specialized blockchain solutions in health identity management and patient engagement. The market is witnessing increased collaboration among healthcare providers, tech innovators, and regulatory bodies to align on standards and interoperability frameworks.\\nStrategic partnerships, acquisitions, and open-source initiatives are driving ecosystem convergence, enabling faster adoption across hospital systems, insurers, and life sciences organizations. By 2035, leading players are expected to consolidate their market positions through AI-integrated blockchain solutions that enhance predictive healthcare analytics and patient-centric service delivery. For new entrants, focusing on niche areas such as decentralized diagnostics, smart contract billing, or pharmaceutical compliance can provide competitive leverage. The evolving competitive dynamics underscore that innovation, interoperability, and trust will remain the defining pillars of success in the U.S. blockchain healthcare market.\\nRequest Free Sample Report @ https://www.researchnester.com/sample-request-5291\\nRelated News -\\nhttps://www.linkedin.com/pulse/what-emerging-trends-shaping-supply-chain-finance-market-bj3if\\nhttps://www.linkedin.com/pulse/what-future-narrowband-iot-market-era-smart-connectivity-d62xf\\nContact Data\\nAJ Daniel\\nCorporate Sales, USA\\nResearch Nester\\n77 Water Street 8th Floor, New York, 10005\\nEmail: info@researchnester.com\\nUSA Phone: +1 646 586 9123\\nEurope Phone: +44 203 608 5919\\nAbout Research Nester\\nResearch Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.\\nThis release was published on openPR.\\nPermanent link to this press release:\\nCopy\\nPlease set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.\\nYou can edit or delete your press release U.S. Blockchain Technology in Healthcare Market: California Shapes the Future of Digital Transformation Through 2026-2035 here\\nNews-ID: 4245372  Views: \\nMore Releases from Research Nester Pvt Ltd\\nLutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicato \\nThe lutein and zeaxanthin market has expanded steadily as demand for eye-health supplements, functional foods, and preventive nutrition increases across global consumer segments. Lutein and zeaxanthin, two essential carotenoids concentrated in the retina, are widely recognized for their protective roles against oxidative stress, age-related macular degeneration (AMD), blue-light exposure, and general visual fatigue. Their adoption has accelerated with the rise of digital lifestyles, an aging population, and growing clinical evidence\\nTop Companies in Atrial Fibrillation Market - Benchmarking Performance & Future \\nThe atrial fibrillation market is undergoing a period of rapid transformation as diagnostic technologies, catheter-based therapies, and antiarrhythmic solutions continue to advance. Atrial fibrillation (AFib) is one of the most prevalent cardiac arrhythmias globally, prompting significant demand for improved detection, early intervention, and minimally invasive treatment. The shift toward advanced ablation systems, AI-enabled diagnostics, wearable monitoring, and next-generation electro-mapping tools has strengthened competition across the market. Companies are expanding their\\nConductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends\\nThe conductive textiles market is undergoing a rapid transformation as wearable electronics, smart apparel, and advanced sensor-integrated fabrics move from niche applications to mainstream adoption. Conductive textiles-engineered using conductive polymers, metal-coated fibers, or intrinsically conductive yarns-have become integral to next-generation healthcare wearables, military gear, automotive interiors, and consumer smart devices. As industries push for lighter, flexible, and more energy-efficient electronic systems, conductive materials embedded within fabrics are emerging as a\\nGlobal Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Inv \\nThe osteosynthesis devices market continues to evolve as orthopedic care moves toward minimally invasive procedures, biologically compatible materials, and technology-enabled implants. These devices-ranging from plates and screws to intramedullary nails and fixation systems-are essential for treating fractures, deformities, and complex bone injuries. Companies operating in this space are adopting strategies centered around product innovation, clinical efficacy, and expansion into fast-growing regions. As trauma care volumes rise in both developed and\\nMore Releases for Blockchain\\nPharmaceutical Blockchain Market to Witness Impressive Growth by 2030: IBM Block \\nAccording to HTF Market Intelligence, the Pharmaceutical Blockchain market to witness a CAGR of 55% during the forecast period (2024-2030).The Latest published a market study on Global Pharmaceutical Blockchain Market provides an overview of the current market dynamics in the Global Pharmaceutical Blockchain space, as well as what our survey respondents- all outsourcing decision-makers- predict the market will look like in 2030. The study breaks the market by revenue and\\nNoticias Blockchain Among the First to Launch of Blockchain for Good Alliance (B \\nNoticias Blockchain is a premier Spanish blockchain news portal helmed by tech-savvy highly experienced journalists specializing in cryptocurrencies and blockchain technologies. The company recently published a comprehensive coverage of BGA's launch.\\nImage: https://www.getnews.info/uploads/70692aa238526d085c2aae051094caca.png\\nThe world of cryptocurrencies and blockchain technologies expands at a rapid pace, witnessing breakthroughs big and small on a seemingly daily basis. To ensure that traders, crypto-curious individuals, investors, and blockchain experts across the globe have instant access\\nFinTech Blockchain Market Is Booming Worldwide | Ripple, Guardtime, Cambridge Bl \\nFinTech Blockchain Market: The extensive research on FinTech Blockchain Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on FinTech Blockchain Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the market, such as market rate, estimated\\nBlockchain Security Market Set for Explosive Growth | DMG Blockchain Solutions, \\nGlobal Blockchain Security Market Growth (Status and Outlook) 2021-2026 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Blockchain Security Market. Some of the key players profiled in the study are Oracle, IBM, Kaspersky, Gemalto,\\nImpact of Outbreak of Coronavirus (Covid-19) on Blockchain in IOT Market by 2027 \\nThe Blockchain in IOT market is expected to garner $6000 million and rise at a CAGR of 70% during the forecast period from 2019 to 2027.\\nA new market report titled Blockchain in IOT Market has been added to the repository of Research N Reports. This report provides comprehensive assessment of the current trends, restrains and futuristic opportunities, which are anticipated to provide lucrative avenues for market proliferation. An in-depth description\\nOodles Blockchain Uses Top Blockchain Platforms To Expedite Blockchain Adoption\\nWith an aim to leverage the blockchain technology to change the centralized system and make it decentralized, Oodles Blockchain has decided to use top blockchain platforms to develop consumer-based blockchain applications.\\nOodles Blockchain, a micro-website of Oodles Technologies, developed mainly to focus on blockchain technology, is delighted to announce that it will be expanding its horizon of blockchain development services by using a few latest open source blockchain platforms like|2025-10-29|https://www.openpr.com/news/4245372/u-s-blockchain-technology-in-healthcare-market-california                                                                                                                                 |\n",
      "|Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn.\\nThe acquisition expedites the entry of Alkermes into the sleep medicine sector.\\nThe transaction received approval from the board of directors of both companies and will conclude in the first quarter of 2026.\\nIt will add Avadels US Food and Drug Administration (FDA)-approved therapy, Lumryz (sodium oxybate), to Alkermes commercial portfolio.\\nThe therapy is used to treat cataplexy or excessive daytime sleepiness in narcolepsy patients over seven years old.\\nThe agreement will be immediately accretive on conclusion, and represents a strategic opportunity, building on Alkermes' operational infrastructure while adding rare disease capabilities.\\nAlkermes CEO Richard Pops stated: This transaction represents a pivotal step in Alkermes' strategic evolution. With the acquisition of Avadel, we are able to accelerate our commercial entry into the sleep medicine market at a critical inflection point as we prepare to advance alixorexton into a Phase III programme in narcolepsy.\\nAvadel's innovative portfolio, commercial capabilities and dedicated employees provide a strong foundation for growth in this therapeutic area. Enabled by our strong balance sheet, this all-cash transaction enhances our revenue growth profile and is expected to be immediately accretive, reinforcing our commitment to delivering long-term value for shareholders.\\nThe combined organisations financial capabilities will enable a broad development strategy for Alkermes orexin-2 receptor agonists portfolio, including ALKS 4510 and ALKS 7290, both currently in Phase I trials.\\nIn December 2023, Novo Nordisk entered a definitive agreement to acquire Alkermess development and manufacturing facility in Athlone, Ireland.\\n\"Alkermes to acquire Avadel for $2.1bn\" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.\\nThe information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |2025-10-23|https://finance.yahoo.com/news/alkermes-acquire-avadel-2-1bn-092504711.html                                                                                                                                                   |\n",
      "+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "only showing top 5 rows\n"
     ]
    }
   ],
   "source": [
    "df = spark.read.json(\"s3a://test/\")\n",
    "df.show(5, truncate=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "7b5afaf4-7de7-4018-8f14-9b486e7d5c06",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DataFrame[content: string, url: string]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "448e0826-f4d9-44d1-a268-3e9ddb79d240",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "root\n",
      " |-- content: string (nullable = true)\n",
      " |-- pub_date: string (nullable = true)\n",
      " |-- url: string (nullable = true)\n",
      "\n"
     ]
    }
   ],
   "source": [
    "df.printSchema()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "72102cb5-a158-43a6-b6d1-8859ae1a5896",
   "metadata": {},
   "source": [
    "# Cleaning"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "b5265173-563a-493f-ba8e-eeade2379323",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "df_columnar = df.withColumn(\n",
    "    \"timestamp\", to_timestamp(col(\"pub_date\"))\n",
    ").withColumn(\n",
    "    \"date\", to_date(col(\"timestamp\"))\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "55c43667-0329-431a-9d01-8c876257d8a8",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"clean_text\",\n",
    "    regexp_replace(col(\"content\"), r\"[\\n\\r\\t]\", \" \")  # remove new lines\n",
    ")\n",
    "\n",
    "# Remove HTML tags\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"clean_text\",\n",
    "    regexp_replace(col(\"clean_text\"), r\"<.*?>\", \"\")\n",
    ")\n",
    "\n",
    "# Remove long sequences of --- +++ === ___ *** etc.\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"clean_text\",\n",
    "    regexp_replace(col(\"clean_text\"), r\"([-=_+*]{3,})\", \" \")\n",
    ")\n",
    "\n",
    "# Normalize multiple spaces\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"clean_text\",\n",
    "    regexp_replace(col(\"clean_text\"), r\"\\s{2,}\", \" \")\n",
    ")\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\"clean_text\", trim(col(\"clean_text\")))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "5d5467d2-df0e-4e4d-b2cd-434c5c80193c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 2:>                                                          (0 + 1) / 1]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|pub_date  |url                                                                                                                                                                                                                           |timestamp          |date      |clean_text                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |\n",
      "+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|2025-11-10|https://www.globenewswire.com/news-release/2025/11/10/3184410/0/en/Genmab-Announces-Proposed-Private-Offering-of-Senior-Secured-Notes-and-Senior-Unsecured-Notes-and-Syndication-of-New-Senior-Secured-Term-Loan-Facility.html|2025-11-10 00:00:00|2025-11-10|Media Release COPENHAGEN, Denmark; November 10, 2025 Genmab A/S (Nasdaq: GMAB) (Genmab) announced today that it and its wholly owned subsidiary Genmab Finance LLC (Genmab Finance) intend to offer, subject to market and other conditions, $1.5 billion of senior secured notes due 2032 (the Secured Notes) and $1.0 billion of senior unsecured notes due 2033 (the Unsecured Notes, and together with the Secured Notes, the Notes). Genmab also launched the syndication of a new $2.0 billion senior secured term loan B facility, which term loan B facility is in addition to a $1.0 billion senior secured term loan A facility and $500 million senior secured revolving credit facility (collectively, the New Credit Facilities) that Genmab previously syndicated to certain lenders as part of the financing for the pending acquisition (the Acquisition) of Merus N.V. (Merus). Genmab intends to use the net proceeds from this offering of the Notes, together with borrowings under the New Credit Facilities and cash on hand, to fund the consideration payable in connection with the Acquisition of Merus and related fees and expenses in connection with the Acquisition, the borrowings under the New Credit Facilities and the issuance of the Notes. Prior to the Acquisition closing, the Notes and the related guarantees from Genmab subsidiaries will be secured solely by segregated securities accounts of Genmab in which the gross proceeds of the Notes will be held. Following the purchase of all Merus common shares tendered in the previously announced tender offer by Genmab, the Secured Notes will be secured by a first priority security interest in certain assets of Genmab and its subsidiaries that will guarantee the obligations under the New Credit Facilities, in accordance with certain customary practices in the relevant jurisdictions, and subject to certain thresholds, exceptions and permitted liens. The Secured Notes will be unconditionally guaranteed on a senior secured basis and the Unsecured Notes will be unconditionally guaranteed on a senior unsecured basis by certain subsidiaries of Genmab that will guarantee the obligations under the New Credit Facilities. The indentures governing the Notes are expected to contain customary covenants that, among other things, restrict, with certain exceptions, the ability of each of Genmab and its subsidiaries to incur additional debt, pay dividends, make certain other restricted payments, incur debt secured by liens, dispose of assets, engage in consolidations and mergers or sell or transfer all or substantially all of its assets. The Notes will not be registered under the Securities Act of 1933, as amended (the Securities Act), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from the registration requirements of or in a transaction not subject to the Securities Act and any state or other applicable securities laws. Accordingly, the offering of the Notes is available only to persons who are either (1) reasonably believed to be qualified institutional buyers as defined in Rule 144A under the Securities Act or (2) non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes will be subject to restrictions on transferability and resale and may not be transferred or resold except in compliance with the registration requirements of the Securities Act or pursuant to an exemption therefrom and in compliance with any state or other applicable securities laws. This announcement shall not constitute an offer to sell or a solicitation of an offer to purchase any securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The offering of the Notes may be made only by means of an offering memorandum. Contact: Marisol Peron, Senior Vice President, Global Communications & Corporate Affairs T: +1 609 524 0065; E:mmp@genmab.com Andrew Carlsen, Vice President, Head of Investor Relations T: +45 3377 9558; E:acn@genmab.com Forward-looking Statements In this announcement, we make statements concerning our expectations, beliefs, plans, objectives, goals, strategies, and future events or performance, including, but not limited to, the statements about the proposed offering of Notes, our intention to issue the Notes and the expected use of proceeds. Genmab cautions investors that any forward-looking statements or projections made by Genmab, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in Genmabs filings with the SEC, including those included in Genmabs most recent Annual Report on Form 20-F, which is available at www.genmab.com and www.sec.gov. Genmab is providing the information in this announcement as of this date, and Genmab does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise. Genmab A/S and/or its subsidiaries own the following trademarks: Genmab; the Y-shaped Genmab logo; Genmab in combination with the Y-shaped Genmab logo; HuMax; DuoBody; HexaBody; DuoHexaBody, HexElect and KYSO. Media Release no. 22 CVR no. 2102 3884 LEI Code 529900MTJPDPE4MHJ122 Genmab A/S Carl Jacobsens Vej 30 2500 Valby Denmark Attachment|\n",
      "+----------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "only showing top 1 row\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    }
   ],
   "source": [
    "df_columnar = df_columnar.drop(\"content\")\n",
    "df_columnar.show(1, truncate=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "c236a7a0-f0cb-4c38-b87b-7696803a9bec",
   "metadata": {},
   "outputs": [],
   "source": [
    "#remove empty articles\n",
    "df_columnar = df_columnar.filter(col(\"clean_text\").isNotNull() & (col(\"clean_text\") != \"\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "476fba71-46d6-46b1-895c-33412cde2c70",
   "metadata": {},
   "outputs": [],
   "source": [
    "#word count\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"word_count\",\n",
    "    size(split(col(\"clean_text\"), r\"\\s+\"))\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "929f8ea1-ef2a-487f-a04f-fa3296769634",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_domain(url):\n",
    "    try:\n",
    "        return urlparse(url).netloc\n",
    "    except:\n",
    "        return None\n",
    "\n",
    "extract_domain_udf = udf(get_domain)\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\"domain\", extract_domain_udf(col(\"url\")))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "29df19ba-0387-4481-805f-184eea24135a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 3:>                                                          (0 + 1) / 1]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------------+\n",
      "|timestamp          |\n",
      "+-------------------+\n",
      "|2025-11-10 00:00:00|\n",
      "|2025-10-14 00:00:00|\n",
      "|2025-10-22 00:00:00|\n",
      "|2025-10-29 00:00:00|\n",
      "|2025-10-23 00:00:00|\n",
      "|2025-10-28 00:00:00|\n",
      "|2025-10-28 00:00:00|\n",
      "|2025-10-18 00:00:00|\n",
      "|2025-10-28 00:00:00|\n",
      "|2025-11-03 00:00:00|\n",
      "|2025-11-03 00:00:00|\n",
      "|2025-11-05 00:00:00|\n",
      "|2025-10-22 00:00:00|\n",
      "|2025-10-19 00:00:00|\n",
      "|2025-10-18 00:00:00|\n",
      "|2025-10-27 00:00:00|\n",
      "|2025-10-18 00:00:00|\n",
      "|2025-10-22 00:00:00|\n",
      "|2025-10-22 00:00:00|\n",
      "|2025-05-21 00:00:00|\n",
      "+-------------------+\n",
      "only showing top 20 rows\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    }
   ],
   "source": [
    "df_columnar.select(\"timestamp\").show(20, truncate=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "56afdaed-2f9b-417c-a9ba-69351fb5667b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "root\n",
      " |-- pub_date: string (nullable = true)\n",
      " |-- url: string (nullable = true)\n",
      " |-- timestamp: timestamp (nullable = true)\n",
      " |-- date: date (nullable = true)\n",
      " |-- clean_text: string (nullable = true)\n",
      " |-- word_count: integer (nullable = true)\n",
      " |-- domain: string (nullable = true)\n",
      "\n"
     ]
    }
   ],
   "source": [
    "df_columnar.printSchema()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "bdb69a03-7793-451f-a9f0-14bc9484529e",
   "metadata": {},
   "outputs": [],
   "source": [
    "columns_to_drop = [\"timestamp\", \"pub_date\", \"url\"]\n",
    "df_columnar = df_columnar.drop(*columns_to_drop)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "aeb0959c-ea2e-4a77-9c37-7600001cbe2c",
   "metadata": {},
   "source": [
    "# Extract Company/Events features"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "e9ab8250-bba7-4ad6-8dee-d615fecb4a00",
   "metadata": {},
   "outputs": [],
   "source": [
    "cosmo_keywords = [\"Cosmo Pharmaceuticals\", \"Cosmo Pharma\"]\n",
    "competitor_keywords = [\"Norgine\", \"TRB Chemedica\", \"EndoChoice\", \"PhaseBio\", \"Alkermes\", \"Genmab\"]\n",
    "industry_keywords = [\"pharma\", \"biotech\", \"drug\", \"healthcare\", \"GI\", \"dermatology\"]\n",
    "def contains_keyword(text, keywords):\n",
    "    text_lower = text.lower()\n",
    "    for kw in keywords:\n",
    "        if kw.lower() in text_lower:\n",
    "            return True\n",
    "    return False\n",
    "\n",
    "is_cosmo_udf = udf(lambda x: contains_keyword(x, cosmo_keywords), BooleanType())\n",
    "is_competitor_udf = udf(lambda x: contains_keyword(x, competitor_keywords), BooleanType())\n",
    "is_industry_udf = udf(lambda x: contains_keyword(x, competitor_keywords), BooleanType())\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\"is_cosmo\", is_cosmo_udf(\"clean_text\")) \\\n",
    "                         .withColumn(\"is_competitor\", is_competitor_udf(\"clean_text\"))\\\n",
    "                         .withColumn(\"is_industry\", is_industry_udf(\"clean_text\"))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "13a12695-1621-4fcf-bed0-a0505d33f74d",
   "metadata": {},
   "outputs": [],
   "source": [
    "clinical_keywords = [\"phase 1\", \"phase 2\", \"phase 3\", \"clinical trial\", \"efficacy\", \"trial results\"]\n",
    "regulatory_keywords = [\"FDA approval\", \"EMA approval\", \"rejection\", \"CRL\", \"complete response letter\"]\n",
    "patent_keywords = [\"patent\", \"intellectual property\", \"IP\", \"exclusivity\"]\n",
    "executive_keywords = [\"CEO\", \"CFO\", \"CBO\", \"board\", \"management change\"]\n",
    "mna_keywords = [\"merger\", \"acquisition\", \"licensing\", \"deal\", \"partnership\"]\n",
    "prodcut_keywords = [\"release\", \"launch\", \"commercialization\", \"approval\"]\n",
    "\n",
    "def detect_event(text, keywords):\n",
    "    text_lower = text.lower()\n",
    "    for kw in keywords:\n",
    "        if kw.lower() in text_lower:\n",
    "            return True\n",
    "    return False\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\"clinical_event\", udf(lambda x: detect_event(x, clinical_keywords), BooleanType())(\"clean_text\")) \\\n",
    "                         .withColumn(\"regulatory_event\", udf(lambda x: detect_event(x, regulatory_keywords), BooleanType())(\"clean_text\")) \\\n",
    "                         .withColumn(\"patent_event\", udf(lambda x: detect_event(x, patent_keywords), BooleanType())(\"clean_text\")) \\\n",
    "                         .withColumn(\"executive_event\", udf(lambda x: detect_event(x, executive_keywords), BooleanType())(\"clean_text\")) \\\n",
    "                         .withColumn(\"mna_event\", udf(lambda x: detect_event(x, mna_keywords), BooleanType())(\"clean_text\"))\\\n",
    "                         .withColumn(\"product_event\", udf(lambda x: detect_event(x, prodcut_keywords), BooleanType())(\"clean_text\"))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "aafd779e-3b44-474d-a8c0-7ad1a2a5f620",
   "metadata": {},
   "outputs": [],
   "source": [
    "analyzer = SentimentIntensityAnalyzer()\n",
    "\n",
    "def vader_sentiment(text):\n",
    "    if not text:\n",
    "        return 0.0\n",
    "    return float(analyzer.polarity_scores(text)[\"compound\"])\n",
    "\n",
    "# Convert to Spark UDF\n",
    "vader_udf = udf(vader_sentiment, DoubleType())\n",
    "\n",
    "# Apply UDF\n",
    "df_columnar = df_columnar.withColumn(\"sentiment_score\", vader_udf(\"clean_text\"))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "6abbe053-a021-4a65-b0a0-41aec17f4e58",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyspark.sql.functions import size, split\n",
    "keywords = [\"phase 1\", \"phase 2\", \"phase 3\", \"clinical trial\", \"efficacy\", \"trial results\",\"FDA approval\", \"EMA approval\", \"rejection\", \"CRL\", \"complete response letter\",\"patent\", \"intellectual property\", \"IP\", \"exclusivity\",\"CEO\", \"CFO\", \"CBO\", \"board\", \"management change\",\"new drug\"]\n",
    "def keyword_count(text):\n",
    "    text_lower = text.lower()\n",
    "    return sum(text_lower.count(kw.lower()) for kw in keywords)\n",
    "\n",
    "df_columnar = df_columnar.withColumn(\n",
    "    \"keyword_count\",\n",
    "    udf(lambda x: keyword_count(x, clinical_keywords), \"int\")(\"clean_text\")\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "71a3603a-9f65-4c0c-8bcc-851d6cfe9124",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "root\n",
      " |-- date: date (nullable = true)\n",
      " |-- clean_text: string (nullable = true)\n",
      " |-- word_count: integer (nullable = true)\n",
      " |-- domain: string (nullable = true)\n",
      " |-- is_cosmo: boolean (nullable = true)\n",
      " |-- is_competitor: boolean (nullable = true)\n",
      " |-- clinical_event: boolean (nullable = true)\n",
      " |-- regulatory_event: boolean (nullable = true)\n",
      " |-- patent_event: boolean (nullable = true)\n",
      " |-- executive_event: boolean (nullable = true)\n",
      " |-- mna_event: boolean (nullable = true)\n",
      " |-- sentiment_score: double (nullable = true)\n",
      " |-- keyword_count: integer (nullable = true)\n",
      "\n"
     ]
    }
   ],
   "source": [
    "df_columnar.printSchema()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "id": "8f8fa779-374e-4440-a04e-27763827192e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_daily = df_columnar.groupBy(\"date\").agg(\n",
    "    F.count(\"*\").alias(\"num_articles\"),\n",
    "    F.sum(F.col(\"is_cosmo\").cast(\"int\")).alias(\"num_cosmo_articles\"),\n",
    "    F.sum(F.col(\"is_competitor\").cast(\"int\")).alias(\"num_competitor_articles\"),\n",
    "    F.sum(F.col(\"is_industry\").cast(\"int\")).alias(\"num_industry_articles\"),\n",
    "    F.avg(\"sentiment_score\").alias(\"avg_sentiment\"),\n",
    "    F.sum(F.col(\"is_cosmo\").cast(\"int\")).alias(\"num_cosmo_articles\"),\n",
    "    F.sum(F.col(\"is_competitor\").cast(\"int\")).alias(\"num_competitor_articles\"),\n",
    "    F.sum(F.col(\"is_industry\").cast(\"int\")).alias(\"num_industry_articles\"),\n",
    "    F.max(\"sentiment_score\").alias(\"max_sentiment\"),\n",
    "    F.min(\"sentiment_score\").alias(\"min_sentiment\"),\n",
    "    F.sum(F.col(\"clinical_event\").cast(\"int\")).alias(\"num_clinical_events\"),\n",
    "    F.sum(F.col(\"regulatory_event\").cast(\"int\")).alias(\"num_regulatory_events\"),\n",
    "    F.sum(F.col(\"patent_event\").cast(\"int\")).alias(\"num_patent_events\"),\n",
    "    F.sum(F.col(\"mna_event\").cast(\"int\")).alias(\"num_mna_events\"),\n",
    "    F.sum(F.col(\"product_event\").cast(\"int\")).alias(\"num_product_events\"),\n",
    "    F.sum(F.when(F.col(\"sentiment_score\") < 0, 1).otherwise(0)).alias(\"num_negative_events\")\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "id": "9b6b077d-8749-43d9-8ea2-1c4ac3791f12",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "root\n",
      " |-- date: date (nullable = true)\n",
      " |-- num_articles: long (nullable = false)\n",
      " |-- num_cosmo_articles: long (nullable = true)\n",
      " |-- num_competitor_articles: long (nullable = true)\n",
      " |-- num_industry_articles: long (nullable = true)\n",
      " |-- avg_sentiment: double (nullable = true)\n",
      " |-- num_cosmo_articles: long (nullable = true)\n",
      " |-- num_competitor_articles: long (nullable = true)\n",
      " |-- num_industry_articles: long (nullable = true)\n",
      " |-- max_sentiment: double (nullable = true)\n",
      " |-- min_sentiment: double (nullable = true)\n",
      " |-- num_clinical_events: long (nullable = true)\n",
      " |-- num_regulatory_events: long (nullable = true)\n",
      " |-- num_patent_events: long (nullable = true)\n",
      " |-- num_mna_events: long (nullable = true)\n",
      " |-- num_product_events: long (nullable = true)\n",
      " |-- num_negative_events: long (nullable = true)\n",
      "\n"
     ]
    }
   ],
   "source": [
    "df_daily.printSchema()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "0a6fd24d-b693-481d-a1a5-4678876bf6fb",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 9:===========================================================(2 + 0) / 2]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+----------+------------+------------------+-----------------------+---------------------+-------------------+------------------+-----------------------+---------------------+-------------+-------------+-------------------+---------------------+-----------------+--------------+------------------+-------------------+\n",
      "|date      |num_articles|num_cosmo_articles|num_competitor_articles|num_industry_articles|avg_sentiment      |num_cosmo_articles|num_competitor_articles|num_industry_articles|max_sentiment|min_sentiment|num_clinical_events|num_regulatory_events|num_patent_events|num_mna_events|num_product_events|num_negative_events|\n",
      "+----------+------------+------------------+-----------------------+---------------------+-------------------+------------------+-----------------------+---------------------+-------------+-------------+-------------------+---------------------+-----------------+--------------+------------------+-------------------+\n",
      "|2025-10-27|1           |0                 |1                      |1                    |0.9962             |0                 |1                      |1                    |0.9962       |0.9962       |1                  |0                    |1                |0             |1                 |0                  |\n",
      "|2025-04-17|3           |0                 |3                      |3                    |0.9754666666666667 |0                 |3                      |3                    |0.9987       |0.9593       |3                  |0                    |2                |3             |3                 |0                  |\n",
      "|2025-09-25|1           |0                 |1                      |1                    |0.9642             |0                 |1                      |1                    |0.9642       |0.9642       |1                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-04-21|1           |0                 |0                      |0                    |0.9592             |0                 |0                      |0                    |0.9592       |0.9592       |0                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-12-11|9           |0                 |6                      |6                    |0.3314888888888889 |0                 |6                      |6                    |0.9999       |-0.9992      |5                  |0                    |9                |7             |9                 |3                  |\n",
      "|2025-12-02|3           |0                 |3                      |3                    |0.9951             |0                 |3                      |3                    |0.998        |0.9926       |1                  |0                    |3                |0             |0                 |0                  |\n",
      "|2025-08-13|2           |0                 |2                      |2                    |0.9210499999999999 |0                 |2                      |2                    |0.9914       |0.8507       |1                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-10-18|3           |0                 |3                      |3                    |-0.5419666666666667|0                 |3                      |3                    |0.3668       |-0.9966      |3                  |0                    |2                |0             |3                 |2                  |\n",
      "|2025-09-16|1           |0                 |1                      |1                    |0.9942             |0                 |1                      |1                    |0.9942       |0.9942       |1                  |0                    |1                |0             |1                 |0                  |\n",
      "|2025-05-02|2           |1                 |1                      |1                    |0.9963500000000001 |1                 |1                      |1                    |0.9982       |0.9945       |1                  |0                    |2                |0             |2                 |0                  |\n",
      "|2025-05-27|1           |0                 |1                      |1                    |0.9757             |0                 |1                      |1                    |0.9757       |0.9757       |1                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-11-03|2           |0                 |2                      |2                    |0.9976             |0                 |2                      |2                    |0.9979       |0.9973       |0                  |0                    |2                |0             |0                 |0                  |\n",
      "|2025-12-09|1           |1                 |0                      |0                    |0.9881             |1                 |0                      |0                    |0.9881       |0.9881       |1                  |0                    |1                |0             |1                 |0                  |\n",
      "|2025-10-01|1           |0                 |1                      |1                    |0.9981             |0                 |1                      |1                    |0.9981       |0.9981       |1                  |0                    |1                |1             |1                 |0                  |\n",
      "|2025-10-14|1           |0                 |1                      |1                    |0.8744             |0                 |1                      |1                    |0.8744       |0.8744       |1                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-04-16|1           |0                 |1                      |1                    |0.7218             |0                 |1                      |1                    |0.7218       |0.7218       |1                  |0                    |1                |1             |1                 |0                  |\n",
      "|2025-12-07|1           |0                 |1                      |1                    |-0.9834            |0                 |1                      |1                    |-0.9834      |-0.9834      |1                  |0                    |1                |0             |1                 |1                  |\n",
      "|2025-11-20|1           |0                 |1                      |1                    |0.9149             |0                 |1                      |1                    |0.9149       |0.9149       |1                  |0                    |1                |0             |0                 |0                  |\n",
      "|2025-12-01|1           |0                 |1                      |1                    |0.9974             |0                 |1                      |1                    |0.9974       |0.9974       |0                  |0                    |1                |1             |1                 |0                  |\n",
      "|2025-11-22|1           |0                 |1                      |1                    |0.998              |0                 |1                      |1                    |0.998        |0.998        |0                  |0                    |1                |0             |1                 |0                  |\n",
      "+----------+------------+------------------+-----------------------+---------------------+-------------------+------------------+-----------------------+---------------------+-------------+-------------+-------------------+---------------------+-----------------+--------------+------------------+-------------------+\n",
      "only showing top 20 rows\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    }
   ],
   "source": [
    "df_daily.show(20, truncate=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "1aac6799-75cb-423f-86f9-dc0a23bd0b2e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 14:>                                                         (0 + 1) / 1]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DataFrame dimensions: 85 rows x 17 columns\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    }
   ],
   "source": [
    "rows = df_daily.count()\n",
    "cols = len(df_daily.columns)\n",
    "print(f\"DataFrame dimensions: {rows} rows x {cols} columns\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "cc96ec0c-dd7d-4ba3-a87c-a77e582e45e4",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 18:=============================>                            (1 + 1) / 2]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+----------+----------+\n",
      "|  min_date|  max_date|\n",
      "+----------+----------+\n",
      "|2024-12-20|2025-12-11|\n",
      "+----------+----------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                "
     ]
    }
   ],
   "source": [
    "df_daily.select(\n",
    "    F.min(\"date\").alias(\"min_date\"),\n",
    "    F.max(\"date\").alias(\"max_date\")\n",
    ").show()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
